Guardant Health insider report: routine RSU conversion lifts CTO holdings
Rhea-AI Filing Summary
On 1 July 2025, Guardant Health, Inc. (GH) filed a Form 4 disclosing routine equity compensation activity by Chief Technology Officer Darya Chudova. Two tranches of previously granted restricted stock units (RSUs) converted into 3,007 common shares at a zero exercise price. To satisfy statutory tax-withholding requirements, 1,525 shares were immediately withheld and disposed of at a market price of $50.71. The net effect is an incremental increase of 1,482 shares, lifting Chudova’s direct beneficial ownership to 81,294 shares.
The derivative table shows Chudova still holds 15,033 unvested RSUs—6,696 from a November 7 2022 grant that vests quarterly through October 2026, and 8,337 from a December 13 2023 grant that vests quarterly through October 2026. Both awards follow typical time-based vesting schedules, and no open-market transactions, 10b5-1 trades, or discretionary sales were reported.
Because the activity stems from standard RSU vesting rather than a voluntary purchase or sale, the filing carries minimal direct market impact. Still, the absence of net selling and the modest increase in insider ownership may be viewed as slightly constructive for investor sentiment.
Positive
- Net increase of 1,482 shares indicates the CTO retained more stock than was withheld for taxes, slightly strengthening insider alignment.
- No discretionary open-market sale at the time of vesting can be read as a constructive, albeit weak, sentiment signal.
Negative
- 1,525 shares disposed at $50.71 to cover taxes, creating minor selling pressure though typical for RSU settlements.
- Transactions are automatic and provide limited insight into management’s view of valuation, thus offering little actionable information.
Insights
TL;DR – Routine RSU vesting; negligible governance signal, modestly positive that no discretionary sales occurred.
This Form 4 reflects standard equity compensation mechanics. Shares were issued upon vesting, and a portion was surrendered for taxes. Such transactions are pre-programmed and do not indicate a proactive insider view of valuation or strategy. Governance risk remains unchanged, and the slight ownership uptick (+1,482 shares) marginally improves alignment with shareholders. No Rule 10b5-1 indicator was checked, suggesting the event was not part of a trading plan but rather automatic. Overall impact on governance perception: neutral.
TL;DR – Neutral trading signal; insider stake rises, but activity is compensation-driven, not valuation-driven.
Investors typically focus on discretionary insider buying or large open-market selling for actionable cues. Here, we see only RSU settlements—3,007 shares issued, 1,525 withheld. The 1,482-share net increase brings total ownership to 81,294 shares, roughly 0.07 % of GH’s 121 million basic shares outstanding—a non-material delta. Lack of open-market sale at ~$51 suggests no bearish positioning, yet absence of cash purchase limits bullish inference. I classify the filing as not impactful for portfolio positioning.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,340 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 1,667 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,340 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,667 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,525 | $50.71 | $77K |
Footnotes (4)
- F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- F2. This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
- F3. Not applicable for Restricted Stock Units.
- F4. This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
AI-generated analysis. How Rhea-AI works. Not financial advice.
